Axcella Health Inc.
AXLA · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1,224 | $1,433 | $13,257 | $13,317 |
| G&A Expenses | $2,319 | $2,750 | $3,500 | $3,776 |
| SG&A Expenses | $2,319 | $2,750 | $3,500 | $3,776 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$10 | -$43 |
| Operating Expenses | $3,543 | $4,183 | $16,757 | $17,093 |
| Operating Income | -$3,543 | -$4,183 | -$20,946 | -$17,093 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $130 | $207 | -$2,054 | -$748 |
| Pre-Tax Income | -$3,413 | -$3,976 | -$23,000 | -$17,841 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,413 | -$3,769 | -$24,257 | -$18,589 |
| % Margin | – | – | – | – |
| EPS | -1.25 | -0.051 | -0.45 | -0.35 |
| % Growth | -2,341.4% | 88.6% | -28.6% | – |
| EPS Diluted | -1.16 | -0.051 | -0.45 | -0.35 |
| Weighted Avg Shares Out | 2,730 | 73,669 | 54,356 | 52,645 |
| Weighted Avg Shares Out Dil | 2,948 | 73,669 | 54,356 | 52,645 |
| Supplemental Information | – | – | – | – |
| Interest Income | $132 | $140 | $294 | $123 |
| Interest Expense | $0 | $0 | $737 | $828 |
| Depreciation & Amortization | $10 | $11 | $9,979 | $211 |
| EBITDA | -$3,403 | -$4,172 | -$10,967 | -$16,882 |
| % Margin | – | – | – | – |